Evidence map›Paper›PMID 33104905›Full record

ArticleNeurosurgical review2021

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy.

Felix Behling, Christina Fodi, Elgin Hoffmann, Mirjam Renovanz, Marco Skardelly, Ghazaleh Tabatabai, Jens Schittenhelm, Jürgen Honegger, Marcos Tatagiba

Abstract read
In one paragraph

Article in Neurosurgical review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Malignant Meningiomas: From Diagnostics to Treatment.Diagnostics (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Neurosurgical treatment and outcome patterns in patients with meningioma in South Moravian region-a population-based study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  16. Article
  17. Review
  18. Meningioma recurrence: Time for an online prediction tool?Surgical neurology international · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Felix BehlingDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany. felixbehling@yahoo.de.ORCID https://orcid.org/0000-0002-1083-1276
Christina FodiDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.
Elgin HoffmannCenter for CNS Tumors, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tuebingen, Germany.
Mirjam RenovanzDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.
Marco SkardellyDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.
Ghazaleh TabatabaiDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.ORCID https://orcid.org/0000-0002-3542-8782
Jens SchittenhelmGerman Cancer Consortium (DKTK), DKFZ partner site Tuebingen, Tuebingen, Germany.ORCID https://orcid.org/0000-0002-9168-6209
Jürgen HoneggerDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.
Marcos TatagibaDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Hoppe-Seyler Street 3, Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the introduction of the Simpson grading for the extent of resection in meningiomas in 1957, its usefulness in modern neurosurgery has been challenged. Especially, the updated WHO classification regarding brain invasion and the efficacy of radiation therapy has not been taken into account when evaluating the prognostic role of the Simpson grading in this era. We analyzed the clinical and histopathological data of 1571 meningiomas that were surgically resected in the authors' institution between July 2003 and March 2017. Operative reports were reviewed regarding the extent of resection according to Simpson grading. Meningioma subtype according to the updated WHO classification of 2016 and clinical characteristics and time to tumor progression were analyzed. The mean follow-up was 38.4 months (range 1.2 to 195.6). A higher rate of tumor recurrence was observed for male gender, younger age, recurrent tumors, non-spinal tumor localization, higher WHO, and Simpson grades in the univariate analysis. In the multivariate analysis older age, recurrent tumors and higher WHO grades remained negative prognostic factors. Among the different Simpson grades, the relative risk for recurrence was highest for grade IV compared to all other grades (each p < 0.0001), while there was no difference between Simpson grades I and II. Adjuvant radiotherapy showed lower rates of tumor recurrence. Subtotal microsurgical resection remains an independent prognostic factor with a higher rate of tumor recurrence. The prognostic benefit of radical treatment of the dural attachment is questionable and needs to be considered when weighing the intraoperative risks of radicality.

Indexed as

Meningeal NeoplasmsMeningiomaFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalNeurosurgical ProceduresRadiotherapy, AdjuvantRetrospective StudiesTreatment OutcomeWorld Health OrganizationMeningiomaPrognosisProgression-free survivalRadiotherapyRecurrenceSimpson grading

Identifiers

PMID33104905
PMCPMC8338836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.